Squalenoylation: A generic platform for nanoparticular drug delivery
详细信息 查看全文
- 作者：Didier Desmaë ; le ; didier.desmaele@u-psud.fr ; Ruxandra Gref ; Patrick Couvreur
- 关键词：Nanoassemblies ; Squalenoylation ; Nucleosidic analogues ; Paclitaxel ; Anticancer activity ; Antiviral activity
- 刊名：Journal of Controlled Release
- 出版年：2012
- 出版时间：20 July, 2012
- 年：2012
- 卷：161
- 期：2
- 页码：609-618
- 全文大小：886 K
文摘
Squalene is a triterpene widely distributed in nature that is an intermediate in the cholesterol biosynthesis pathway. The remarkable dynamic folded conformation of squalene has been used to chemically conjugate this lipid with various therapeutic molecules to construct nanoassemblies of 100-300 nm. In this review, we discuss the new concept of ¡°squalenoylation?through application to anticancer (i.e. gemcitabine, paclitaxel, cisplatin etc.? or antiviral (ddI, ddC) compounds. In a lego-type approach, it is also possible to construct multifunctional nanoparticles endowed with additional imaging functionalities (i.e. ¡°Nanotheragnostics?. This new nanotechnology platform is expected to have important applications in pharmacology.